Advertisement
Screener

AGENUS INC (AGEN) ROA

AGENUS INC ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • AGENUS INC roa for the quarter ending 2026-06-30 was 53.24%, a change of 145.24% year-over-year.
  • AGENUS INC roa for the quarter ending 2026-03-31 was 33.52%, a change of 131.01% year-over-year.
  • AGENUS INC roa for the quarter ending 2025-12-31 was -1.36%, a change of 101.29% year-over-year.
  • AGENUS INC roa for the quarter ending 2025-09-30 was -16.79%, a change of 81.35% year-over-year.
  • AGENUS INC roa for fiscal 2025 was -1.36%, a change of 101.29% from fiscal 2024.
  • AGENUS INC roa for fiscal 2024 was -102.65%, a change of -20.64% from fiscal 2023.
  • AGENUS INC roa for fiscal 2023 was -82.01%, a change of -26.24% from fiscal 2022.
  • AGENUS INC roa for fiscal 2022 was -55.77%, a change of -49.61% from fiscal 2021.
Available history
2010-12-31 to 2026-06-30
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-3053.24%$91.94M-$550.00K$172.69M
2026-03-3133.52%$62.49M$186.46M
2025-12-31-1.36%-$3.08M-$10.58M$226.8M
2025-09-30-16.79%-$39.28M$63.91M$233.89M
2025-06-30-92.00%-$170.4M-$27.95M$185.22M
2025-03-31-97.50%-$195.19M$200.2M
2024-12-31-102.65%-$232.27M-$45.86M$226.27M
2024-09-30-98.14%-$234.05M-$66.39M$238.48M
2024-06-30-79.12%-$231.37M$292.42M
2024-03-31-97.44%-$250M$256.56M
2023-12-31-82.01%-$257.44M-$46.29M$313.91M
2023-09-30-84.35%-$282.96M-$62.20M$335.47M
2023-06-30-71.73%-$275.14M$383.59M
2023-03-31-60.78%-$250.95M$412.85M
2022-12-31-55.77%-$230.66M-$71.09M$413.56M
2022-09-30-52.25%-$224.16M-$54.22M$429.02M
2022-06-302.16%$9.83M$456.17M
2022-03-31-5.65%-$24.92M$441.31M
2021-12-31-6.16%-$28.72M-$65.51M$465.96M
2021-09-300.26%$1.15M$178.55M$437.64M
2021-06-30-118.45%-$227.77M$192.3M
2021-03-31-81.74%-$192.02M$234.92M
2020-12-31-85.26%-$182.89M-$37.73M$214.51M
2020-09-30-86.08%-$176.01M-$51.65M$204.48M
2020-06-30-91.85%-$170.64M-$48.24M$185.78M
2020-03-31-96.78%-$174.27M-$45.27M$180.06M
2019-12-31-71.82%-$111.56M-$30.85M$155.34M
2019-09-30-74.11%-$129.56M-$46.28M$174.81M
2019-06-30-56.61%-$117.01M-$51.87M$206.71M
2019-03-31-36.74%-$90.34M$17.43M$245.93M
2018-12-31-118.83%-$162.08M-$48.85M$136.4M
2018-09-30-113.63%-$148.27M-$33.73M$130.48M
2018-06-30-114.73%-$151.38M-$25.20M$131.94M
2018-03-31-120.70%-$157.89M-$54.26M$130.82M
2017-12-31-87.20%-$120.69M-$35.03M$138.4M
2017-09-30-74.89%-$111.78M-$36.84M$149.27M
2017-06-30-65.56%-$115.71M-$31.71M$176.49M
2017-03-31-55.26%-$112.32M-$17.10M$203.27M
2016-12-31-80.90%-$127M-$26.12M$156.99M
2016-09-30-66.62%-$116.48M-$40.77M$174.84M
2016-06-30-45.22%-$88.83M-$28.32M$196.45M
2016-03-31-45.64%-$100.92M-$31.78M$221.14M
2015-12-31-36.28%-$87.88M-$15.61M$242.23M
2015-09-30-40.50%-$98.25M-$13.12M$242.61M
2015-06-30-51.77%-$93.24M-$40.41M$180.11M
2015-03-31-51.88%-$60.87M-$18.74M$117.32M
2014-12-31-57.01%-$42.49M-$25.98M$74.53M
2014-09-30-25.43%-$22.29M-$8.11M$87.63M
2014-06-30-21.45%-$21.49M-$8.04M$100.19M
2014-03-31-22.71%-$24.6M-$357.00K$108.3M
2013-12-31-86.33%-$30.07M-$5.78M$34.84M
2013-09-30-78.94%-$29.74M-$7.32M$37.67M
2013-06-30-131.70%-$28.15M-$11.14M$21.37M
2013-03-31-95.20%-$23.93M-$5.83M$25.13M
2012-12-31-38.93%-$11.32M-$5.44M$29.09M
2012-09-30-36.95%-$11.91M-$5.73M$32.22M
2012-06-30-35.20%-$11.71M-$6.92M$33.27M
2012-03-31-31.76%-$10.54M$6.77M$33.21M
2011-12-31-117.51%-$23.28M-$6.02M$19.81M
2011-09-30-80.73%-$19.67M-$5.53M$24.37M
2011-06-30-89.27%-$19.84M-$5.76M$22.23M

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-31-1.36%-$3.08M$226.8M
2024-12-31-102.65%-$232.27M$226.27M
2023-12-31-82.01%-$257.44M$313.91M
2022-12-31-55.77%-$230.66M$413.56M
2021-12-31-6.16%-$28.72M$465.96M
2020-12-31-85.26%-$182.89M$214.51M
2019-12-31-71.82%-$111.56M$155.34M
2018-12-31-118.80%-$162.04M$136.4M
2017-12-31-87.20%-$120.69M$138.4M
2016-12-31-80.90%-$127M$156.99M
2015-12-31-36.28%-$87.88M$242.23M
2014-12-31-57.01%-$42.49M$74.53M
2013-12-31-86.33%-$30.07M$34.84M
2012-12-31-38.93%-$11.32M$29.09M
2011-12-31-117.51%-$23.28M$19.81M
2010-12-31-70.88%-$21.91M$30.91M

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60